MedLumics secures 34.4 million euros in Series B Funding

by Ysios Capital

MedLumics, a cardiac device company specializing in optically guided minimally invasive instruments, announced today that it has raised 34.4 million Euros in financing that will be used to help advanc...

Read more

STAT-Diagnostica Attracts Siemens Venture Capital as a New Investor

by Ysios Capital

Led by Gilde Healthcare, the Series C financing round also drew participation from existing investors, including Kurma Partners; Ysios Capital; Idinvest Partners; Boehringer Ingelheim Venture Fund; Ca...

Read more
Subscribe to Directory
Write an Article

Highlight

3i closes second European CLO, Harvest V...

by 3i Group

3i Group plc (“3i” or “3i Group”), an international investor, ...

Inkemia pondrá en marcha un fondo de oc...

by InKemia IUCT group

La compañía quiere invertir en 24 empresas españolas en los próxim...

Photos Stream